Your account is not claimed yet. You can sign up with ORCID to claim your account.

Nahed Nasser Eid El-Sayed (Nahed N E El-Sayed)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Cardiopulmonary Resuscitation

Molecular Docking

Silver Nanoparticles

Top Venues

Pharmaceuticals (Basel, Switzerland)

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Nahed Nasser Eid El-Sayed, Magdi E A Zaki, Sami A Al-Hussain, Abir Ben Bacha, Malika Berredjem, Vijay H Masand, Zainab M Almarhoon, Hanaa S Omar
Synthesis and Evaluation of Some New 4 H -Pyran Derivatives as Antioxidant, Antibacterial and Anti-HCT-116 Cells of CRC, with Molecular Docking, Antiproliferative, Apoptotic and ADME Investigations. Pharmaceuticals (Basel, Switzerland) 15 (7) (2022)
Nahed Nasser Eid El-Sayed, Norah M Almaneai, Abir Ben Bacha, Mohamed Kandeel El-Ashrey, Maha I Al-Zaben, Zainab M Almarhoon
Biological Evaluation, Molecular Docking Analyses, and ADME Profiling of Certain New Quinazolinones as Anti-colorectal Agents. ACS omega 7 (22) (2022)
Nahed Nasser Eid El-Sayed, Taghreed M Al-Otaibi, Mona A Alonazi, Vijay H Masand, Assem Barakat, Zainab M Almarhoon, Abir Ben Bacha
Synthesis and Characterization of Some New Quinoxalin-2(1H)one and 2-Methyl-3H-quinazolin-4-one Derivatives Targeting the Onset and Progression of CRC with SRA, Molecular Docking, and ADMET Analyses. Molecules (Basel, Switzerland) 26 (11) (2021)
Shimaa Kamal, Hamed Ahmed Derbala, Seham Soliman Alterary, Abir Ben Bacha, Mona Alonazi, Mohamed Kandeel El-Ashrey, Nahed Nasser Eid El-Sayed
Synthesis, Biological, and Molecular Docking Studies on 4,5,6,7-Tetrahydrobenzo[b]thiophene Derivatives and Their Nanoparticles Targeting Colorectal Cancer. ACS omega 6 (43) (2021)